ACM Global Central Lab is a global force in central laboratory testing for clinical trials.
We specialize in delivering the highest quality laboratory science in support of clinical research services. Our flexible approach, attention to detail and customer service sets us apart from the competition.
Our analytical team performs more than 13 million tests each year spanning all medical disciplines, including Pathology, Microbiology, Flow Cytometry and specialized Biomarkers.
We operate in more than 60 countries around the globe and have a 10 year track record of doing so.
Find out more about ACM's unique philosophy on delivering central laboratory services.
It comes as some surprise to many working within clinical trials that drug-induced liver injury (DILI) is the single most frequent cause of safety-related drug marketing withdrawals today and has been for more than 50 years now. Yet despite this fact, there is still very little understanding within the drug community as to the monitoring that can be performed to identify the potential of DILI early on within a trial. 
Mixx
Digg
Facebook
del.icio.us
Twitter
MySpace
StubmleUpon
